Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices 15619 

• Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated electronic, 

mechanical, or other technological 

collection techniques, or other forms of 

information technology, e.g., permitting 

electronic submissions of responses. 

I. Background 

IMLS is the primary source of federal 

support for the Nation’s libraries and 

museums. We advance, support, and 

empower America’s museums, libraries, 

and related organizations through grant 

making, research, and policy 

development. To learn more, visit 

www.imls.gov. 

II. Current Actions 

This Notice proposes renewing the 

clearance of the content, forms, and 

instructions for IMLS Library and 

Museum Reviewer Forms for the next 

three years. 

All proposals submitted for IMLS 

competitive awards are reviewed by 

library and museum professionals who 

know the needs of communities, can 

share promising practices, and are well 

versed in the issues and concerns of 

libraries and museums today. Peer 

reviewers dedicate their time and 

expertise to advance the highest 

professional practices in the field. The 

IMLS review process is well respected, 

and the success of our grant programs is 

largely due to the expertise of our 

reviewers. These peer reviewer forms, 

accessed through the IMLS website, 

allow library and museum professionals 

to indicate their interest and provide 

information on their professional 

expertise to be considered for selection 

as an IMLS peer reviewer. 

Agency: Institute of Museum and 

Library Services. 

Title: IMLS Library and Museum 

Reviewer Forms. 

OMB Control Number: 3137–0099. 

Agency Number: 3137. 

Affected Public: Library and Museum 

professionals. 

Total Estimated Number of Annual 

Responses: 1,450. 

Frequency of Response: Once per 

year. 

Average Minutes per Response: 15. 

Total Estimated Annual Burden 

Hours: 363. 

Total Annual Burden: $11,649. 

Total Annual Federal Costs: $3,989. 

Public Comments Invited: Comments 

submitted in response to this Notice 

will be summarized and/or included in 

the request for OMB’s clearance of this 

information collection. 

Dated: February 27, 2024. 

Suzanne Mbollo, 

Grants Management Specialist, Institute of 

Museum and Library Services. 

[FR Doc. 2024–04411 Filed 3–1–24; 8:45 am] 

BILLING CODE 7036–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Charter Renewal 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Notice of renewal of the Charter 

of the Advisory Committee on the 

Medical Uses of Isotopes. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) has determined that 

renewal of the charter for the Advisory 

Committee of the Medical Uses of 

Isotopes (ACMUI) until February 28, 

2026, is in the public interest in 

connection with duties imposed on the 

Commission by law. This action is being 

taken in accordance with the Federal 

Advisory Committee Act, after 

consultation with the Committee 

Management Secretariat, General 

Services Administration. 

SUPPLEMENTARY INFORMATION: The 

purpose of the ACMUI is to provide 

advice to the NRC on policy and 

technical issues that arise in regulating 

the medical use of byproduct material 

for diagnosis and therapy. 

Responsibilities include providing 

guidance and comments on current and 

proposed NRC regulations and 

regulatory guidance concerning medical 

use; evaluating certain non-routine uses 

of byproduct material for medical use; 

and evaluating training and experience 

of proposed authorized users. The 

members are involved in preliminary 

discussions of major issues in 

determining the need for changes in 

NRC policy and regulation to ensure the 

continued safe use of byproduct 

material. Each member provides 

technical assistance in his/her specific 

area(s) of expertise, particularly with 

respect to emerging technologies. 

Members also provide guidance as to 

NRC’s role in relation to the 

responsibilities of other Federal 

agencies as well as of various 

professional organizations and boards. 

Members of this Committee have 

demonstrated professional 

qualifications and expertise in both 

scientific and non-scientific disciplines 

including nuclear medicine; nuclear 

cardiology; radiation therapy; medical 

physics; nuclear pharmacy; State 

medical regulation; patient’s rights and 

care; health care administration; and 

Food and Drug Administration 

regulation. 

Contact Information: Lillian 

Armstead, Office of Nuclear Material 

Safety and Safeguards, U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555; email: Lillian.Armstead@

nrc.gov. 

Dated at Rockville, Maryland this 28th day 

of February, 2024. 

For the U.S. Nuclear Regulatory 

Commission. 

Russell E. Chazell, 

Federal Advisory Committee Management 

Officer. 

[FR Doc. 2024–04462 Filed 3–1–24; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2024–0001] 

Sunshine Act Meetings 

TIME AND DATE: Weeks of February 

March 4, 11, 18, 25, and April 1, 8, 

2024. The schedule for Commission 

meetings is subject to change on short 

notice. The NRC Commission Meeting 

Schedule can be found on the internet 

at: https://www.nrc.gov/public-involve/ 

public-meetings/schedule.html. 

PLACE: The NRC provides reasonable 

accommodation to individuals with 

disabilities where appropriate. If you 

need a reasonable accommodation to 

participate in these public meetings or 

need this meeting notice or the 

transcript or other information from the 

public meetings in another format (e.g., 

braille, large print), please notify Anne 

Silk, NRC Disability Program Specialist, 

at 301–287–0745, by videophone at 

240–428–3217, or by email at 

Anne.Silk@nrc.gov. Determinations on 

requests for reasonable accommodation 

will be made on a case-by-case basis. 

STATUS: Public and closed. 

Members of the public may request to 

receive the information in these notices 

electronically. If you would like to be 

added to the distribution, please contact 

the Nuclear Regulatory Commission, 

Office of the Secretary, Washington, DC 

20555, at 301–415–1969, or by email at 

Betty.Thweatt@nrc.gov or 

Samantha.Miklaszewski@nrc.gov. 

MATTERS TO BE CONSIDERED: 

Week of March 4, 2024 

Thursday, March 7, 2024 

10:00 a.m.—Briefing on NRC 

International Activities (Closed Ex. 

1 and 9) 


khammond on DSKJM1Z7X2PROD with NOTICES